✦ LIBER ✦

The Orphan Drug Act and the Development of Stem Cell-Based Products for Rare Diseases

✍ Scribed by Scott N. Freeman; Kathryn A. Burke; Menfo A. Imoisili; Timothy R. Coté

Book ID: 116891366
Publisher: Elsevier
Year: 2010
Tongue: English
Weight: 297 KB
Volume: 7
Category: Article
ISSN: 1934-5909
DOI: 10.1016/j.stem.2010.08.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Impact of the Orphan Drug Act on the

The Impact of the Orphan Drug Act on the Development and Advancement of Neurological Products for Rare Diseases: A Descriptive Review

✍ Burke, K A; Freeman, S N; Imoisili, M A; Coté, T R 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 105 KB

Fueling the development of products for

Fueling the development of products for rare diseases: the impact of the FDA’s orphan products grants program

✍ Imoisili, Menfo A; Mueller, Christine; Needleman, Katherine I Miller 📂 Article 📅 2014 🏛 Informa UK (Taylor & Francis) 🌐 English ⚖ 554 KB

Are rare diseases still orphans or happi

Are rare diseases still orphans or happily adopted? The challenges of developing and using orphan medicinal products

✍ James W. Dear; Pajaree Lilitkarntakul; David J. Webb 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB

PHP7 Orphan Drugs for Rare Diseases in t

PHP7 Orphan Drugs for Rare Diseases in the European Union: Bridging the Gap between Drug Development and Unmet Medical Needs?

✍ F. Catalá-López; S. Peiró; R. Gènova-Maleras; A. Garcia-Altés; G. Sanfélix-Gimen 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Nuclear Reprogramming and Stem Cells ||

Nuclear Reprogramming and Stem Cells || The Generation of Disease-Specific Cell Lines and Their Use for Developing Drug Therapies

✍ Ainscough, Justin; Yamanaka, Shinya; Tada, Takashi 📂 Article 📅 2011 🏛 Humana Press 🌐 English ⚖ 256 KB

Research into the field of stem cell biology has developed exponentially over recent years, and is beginning to offer significant promise for unravelling the molecular basis of a multitude of disease states. Importantly, in addition to offering the opportunity to delve deeply into the mechanisms tha

The Role of Academic Institutions in the

The Role of Academic Institutions in the Development of Drugs for Rare and Neglected Diseases

✍ Coles, L D; Cloyd, J C 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 417 KB